Theriva Biologics, Inc.
TOVX
$0.25
$0.014.52%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.43M | 13.06M | 7.53M | 12.12M | 10.01M |
| Total Receivables | 1.79M | 3.84M | 1.82M | 1.88M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 540.00K | 576.00K | 551.00K | 696.00K | 687.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 48.00K | 79.00K |
| Total Current Assets | 16.76M | 17.47M | 9.90M | 14.74M | 12.48M |
|
|
|||||
| Total Current Assets | 16.76M | 17.47M | 9.90M | 14.74M | 12.48M |
| Net Property, Plant & Equipment | 2.14M | 1.03M | 1.19M | 1.34M | 1.42M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.35M | 19.75M | 19.74M | 19.75M | 18.26M |
| Total Assets | 38.25M | 38.24M | 30.84M | 35.83M | 32.16M |
|
|
|||||
| Total Accounts Payable | 608.00K | 1.01M | 795.00K | 607.00K | 437.00K |
| Total Accrued Expenses | 6.49M | 6.72M | 8.43M | 9.78M | 4.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 545.00K | 606.00K | 675.00K | 668.00K | 619.00K |
| Total Finance Division Other Current Liabilities | 2.62M | 1.68M | 1.10M | 1.34M | 2.77M |
| Total Other Current Liabilities | 2.62M | 1.68M | 1.10M | 1.34M | 2.77M |
| Total Current Liabilities | 10.26M | 10.01M | 11.00M | 12.39M | 8.15M |
|
|
|||||
| Total Current Liabilities | 10.26M | 10.01M | 11.00M | 12.39M | 8.15M |
| Long-Term Debt | 1.63M | 1.67M | 1.65M | 1.64M | 1.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.52M | 352.00K | 433.00K | 584.00K | 732.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.44M | 10.82M | 11.01M | 10.59M | 6.28M |
| Total Liabilities | 22.85M | 22.86M | 24.10M | 25.21M | 16.66M |
|
|
|||||
| Common Stock & APIC | 376.06M | 373.63M | 362.98M | 362.47M | 355.60M |
| Retained Earnings | -360.75M | -358.71M | -356.71M | -352.35M | -339.30M |
| Treasury Stock & Other | 89.00K | 467.00K | 475.00K | 505.00K | -812.00K |
| Total Common Equity | 15.40M | 15.38M | 6.74M | 10.62M | 15.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.40M | 15.38M | 6.74M | 10.62M | 15.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.40M | 15.38M | 6.74M | 10.62M | 15.50M |
|
|
|||||